Epigenetic Regulators of Mesenchymal Stem/Stromal Cell Lineage Determination.
Dimitrios CakourosStan GronthosPublished in: Current osteoporosis reports (2021)
This review discusses how specific enzymes that modify histone methylation and acetylation or DNA methylation orchestrate the differentiation programs in lineage determination of MSC and the epigenetic changes that facilitate development of bone related diseases such as osteoporosis. The review also describes how environmental factors such as mechanical loading influence the epigenetic signatures of MSC, and how the use of chemical agents or small peptides can regulate epigenetic drift in MSC populations during ageing and disease. Epigenetic regulation of MSC lineage commitment is controlled through changes in enzyme activity, which modifies DNA and histone residues leading to alterations in chromatin structure. The co-ordinated epigenetic regulation of transcriptional activation and repression act to mediate skeletal tissue homeostasis, where deregulation of this process can lead to bone loss during ageing or osteoporosis.
Keyphrases
- dna methylation
- genome wide
- gene expression
- bone loss
- single cell
- bone mineral density
- postmenopausal women
- transcription factor
- bone marrow
- copy number
- stem cells
- public health
- molecularly imprinted
- body composition
- high resolution
- soft tissue
- cell therapy
- mesenchymal stem cells
- oxidative stress
- tandem mass spectrometry
- histone deacetylase